By Dr. Gavin Magaha PharmD MS – The current turmoil surrounding the 340B Drug Pricing Program and Medicaid Drug Rebate Program. Bloomberg Law, recently reported that pharmaceutical manufacturers and a trade organization have filed at least 23 that extend 340B drug discounts to an unlimited number of contract pharmacies.
Read More
The pharmaceutical market plays a key role in how people get medications and what people pay for medication. At the intersection of healthcare, pharma, and technology, here are current news and announcements.
By Jason Ausili PharmD – As interoperability provisions from the Cures Act enter their enforcement phase, pharmacy leaders within the Pharmacy HIT Collaborative, the U.S. Department of Health and Human Services’ Office of the National Coordinator for Health Information Technology, and pharmacy system vendors, met recently to discuss the state of pharmacy interoperability.
Next step in the intrusion of commercial interests in EHRs As far as I can tell the first advertisements appeared in 17th century newspapers. According…